PAUL CORN to Liver Neoplasms
This is a "connection" page, showing publications PAUL CORN has written about Liver Neoplasms.
Connection Strength
0.064
-
A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapy. Sci Transl Med. 2022 04 20; 14(641):eabm6420.
Score: 0.064